Potent enhancement of GFP uptake into HT-29 cells and rat skin permeation by coincubation with tat peptide

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 4766-4773

  Lohcharoenkal, Warangkana ^a   Manosaroi, Aranya ^a   Götz, Friedrich ^b   Werner, Rolf G ^c   Manosroi, Worapaka ^a   Manosaroi, Jiradej ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cell culture; Drug delivery systems; Epithelial delivery permeability; Peptides; Protein delivery; Transdermal

Indexed keywords

CELL PENETRATING PEPTIDE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TRANS ACTIVATING TRANSCRIPTIONAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL STRAIN HT29; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DERMIS; DRUG DELIVERY SYSTEM; EPIDERMIS; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NONHUMAN; PROTEIN TRANSPORT; RAT; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 80053287585     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22671     Document Type: Article

References (33)

1. Rinne J, Albarran B, Jylhävä J, Ihalainen TO, Kankaanpää P, Hytönen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M. 2007. Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol 7:1-14.
2. Lindgren M, Hallbrink M, Prochiantz A, Langel Ü. 2000. Cell-penetrating peptides. Trends Pharmacol Sci 21:99-103.
3. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. 2003. Cell penetrating peptides: A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585-590.
4. Tünnermann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. 2006. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 20:1775-1784.
5. Schwarze SR, Hruska KA, Dowdy SF. 2000. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol 10:290-295.
6. Vives E. 2003. Cellular uptake of the Tat peptide: An endocytosis mechanism following ionic interactions. J Mol Recognit 16(5):265-271.
7. Myrberg H, Lingren M, Langel Ü. 2007. Protein delivery by the cell-penetrating peptide YTA2. Bioconjug Chem 18:170-174.
8. Bradford MA. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112.
10. Górska P. 2000. Principles in laboratory animal research for experimental proposes. Med Sci Monit 6(1):171-180.
11. Plessis J, Egbaria K, Weiner N. 1992. Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J Soc Cosmet Chem 43:93-100.
12. Kühnel F, Schulte B, Wirth T, Woller N, Schäfers S, Zender L, Manns M, Kubicka S. 2004. Protein transduction domains fused to virus receptor improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 78:13743-13754.
13. Giaginis CT, Zarros AC, Papaefthymiou MA, Papadopouli AE, Sfiniadakis IK, Theocharis SE. 2008. Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinama: Possible clinical implications. World J Surg Oncol 6:59.
14. Manosroi J, Lohcharoenkal W, Götz F, Werner RG, Manosroi W, Manosroi A. 2011. Transdermal absorption enhancement of N-terminal Tat-GFP fusion protein (TG) loaded in novel low toxic elastic anionic niosomes. J Pharm Sci 100(4):1525-1534.
15. Lee HE, Lee MJ, Park CR, Kim AY, Chun KH, Hwang HJ, Oh DH, Jeon SO, Kang JS, Jung TS, Choi GJ, Lee S. 2010. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. J Control Release 143:251-257.
16. Ziegler A, Nervi P, Dürrenberger M, Seelig J. 2005. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: Optical, biophysical, and metabolic evidence. Biochemistry 44:138-148.
17. Morris MC, Chaloin L, Mery J, Heitz F, Divita G. 1999. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res 27:3510-3517.
18. Gros E, Deshayes S, Morris MC, Aldrian-Herrada G, Depollier J, Heitz F, Divita G. 2006. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim Biophys Acta 1758:384-393.
19. Hu JW, Liu BR, Wu CY, Lu SW, Lee HJ. 2009. Protein transport in human cells mediated by covalently and noncovalently conjugated arginine-rich intracellular delivery peptides. Peptides 30:1669-1678.
20. Liu Q, Yuan YC, Shen B, Chen DJ, Chen Y. 1999. Conformational flexibility of a ubiquitin conjugation enzyme (E2). Biochemistry 38:1415-1425.
21. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Tsunoda S, Tsutsum Y. 2010. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 65(3):199-201.
22. Varshavsky A. 1997. The N-end rule pathway of protein degradation. Genes Cells 2:13-28.
23. Lin-Lee YC, Nakamura S, Gandhi V, Curley SA, Stüber D, Burkot TR, Kuo MT. 2002. Prolonged stability and sustained prodrug cell killing activity using receptor-mediated delivery of malarial circumsporozoite-cytosine deaminase fusion protein into liver cancer cells. Mol Cancer Ther 1:461-467.
24. Bhattacharjee S, Han L, Evers NM, Jiang X, Marcelis A, Zuilhof H, Rietjens I, Alink GM. 2010. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol 7:25.
25. El-Andaloussi S, Järver P, Johansson HJ, Langel Ü. 2007. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: A comparative study. Biochem J 407:285-292.
26. Kroll A, Dierker C, Rommel C, Hahn D, Wohlleben W, Schulze-Isfort C, Göbbert C, Voetz M, Hardinghaus F, Schnegenburger J. 2011. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of 10 cell lines and three different assays. Part Fibre Toxicol 8:9-27.
27. Gray KM, Banada PP, O'Neal E, Bhunia AK. 2005. Rapid Ped-2E9 cell-based cytotoxicity analysis and genotyping of Bacillus species. J Clin Microbiol 43(12):5865-5872.
28. Guo X, Hutcheon AEK, Zieske JD. 2004. TAT-mediated protein transduction into human corneal epithelial cells: p15(INK4b) inhibits cell proliferation and stimulates cell migration. Invest Ophthalmol Vis Sci 45(6):1804-1811.
29. Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM. 2009. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol 215(2):253-263.
30. Riss TL, Moravec RA. 2004. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2(1):51-62.
31. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A. 2003. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res 20(10):1543-1550.
32. Kim J, Shim J, Kim YJ, Char K, Suh KD, Kim JW. 2010. The design of polymer-based nanocarriers for effective transdermal delivery. Macromol Biosci 10(10):1171-1176.
33. Amsden BG, Goosen MFA. 2004. Transdermal delivery of peptide and protein drugs: An overview. Am Chem Eng 41:1972-1997.